These findings suggest that the levels of NGF in the tumor microenvironment could influence the extent of angiogenesis and tumor progression, providing a mechanistic basis for targeting NGF-TrkA-PDGF-C signaling as a therapeutic strategy. The gene discussed is NGF; the disease is neoplasm.